Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer
, prednisoneb
16 (15)
āLeuprolide, enzalutamideb
11 (11)
āLeuprolide, abiraterone, prednisone, apalutamidec
36 (35)
āLeuprolide, abiraterone, prednisonec
41 (39)
Gleason score
ā7 28 (27)
ā8 31 (30)
ā9 43 (41)
ā10 2 (1.9)
RP staging
ā<T3 75 (73)
āā„T3 28 (27)
āUnknown 1
Abbreviations
, prednisoneb
16 (15)
āLeuprolide, enzalutamideb
11 (11)
āLeuprolide, abiraterone, prednisone, apalutamidec
36 (35)
āLeuprolide, abiraterone, prednisonec
41 (39)
Gleason score
ā7 28 (27)
ā8 31 (30)
ā9 43 (41)
ā10 2 (1.9)
RP staging
ā<T3 75 (73)
āā„T3 28 (27)
āUnknown 1
Abbreviations